|

Ziltivekimab Clinical Trials

3 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Pipeline

Phase 3: 3

Top Sponsors

  • Novo Nordisk A/S2
  • ECRI bv1

Indications

  • Heart Disease3
  • Coronary Atherosclerosis of Native Coronary Artery1
  • Systemic Inflammation1
  • Acute Myocardial Infarction (AMI)1
  • Myocardial Infarction1

Other2 trials

A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Phase 3

Alexander City, Alabama1 trial

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

Advanced Cardiovascular, LLC

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.